Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00245258Phase 4Completed
Phase 4, randomised, double-blind trial of sildenafil in erectile dysfunction (ED) (3 arms), sponsored by Viatris. Primary endpoint: International Index of Erectile Function - Erectile Function Domain at 8 weeks. Started Nov 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00245258.